Joseph McCracken

Dr. Joseph S.
McCracken is a Lead Independent Director at Savara, Inc. He is on the Board of Directors at Neuropore Therapies, Inc., Modalis Therapeutics Corp., REGiMMUNE Corp., Savara, Inc. and Eos Therapies, Inc. Dr. McCracken was previously employed as an Independent Director by Lumos Pharma, Inc., an Independent Director by Kindred Biosciences, Inc., a Non-Executive Director by Nexvet Australia Pty Ltd., an Independent Non-Executive Director by Nexvet Biopharma Plc, a VP, Global Head-Business Development & Licensing by Roche Pharmaceuticals, Inc., a VP, Global Head-Business Development & Licensing by Hoffmann-La Roche, Inc., a General Manager by Roche Diagnostics KK, a Vice President-Business Development by Genentech, Inc., a Vice President-Business Development by Rhone-Poulenc Rorer SA, and a Vice President-Business Development by Aventis Pharmaceuticals, Inc. He also served on the board at NewLink Genetics Corp., Alkahest, Inc., Aravas, Inc., Calliditas Therapeutics France SAS and GenKyoTex Suisse SA. He received his undergraduate degree from The Ohio State University, a graduate degree from The Ohio State University and a doctorate degree from The Ohio State University.